The United States says to distribute the corona vaccine in November

Experts are urging the world to distribute the covid vaccine right now due to the Corona epidemic. On the other hand, the US government has announced that on November 01, Corona vaccine distribute. This announcement is not science-based strategy but a presidential voting strategy. The election is scheduled to take place later this year.

Letter to the Governor for distribution of vaccines

In a letter to the governor on August 27, Robert Redfield, director of the US Centers for Disease Control and Prevention (CDC), said McCasson Corp. would seek country approval in the near future. The department and the hospital have agreed to distribute the vaccine. The US CDC is likely to get the vaccine in some health departments

The supply of vaccines will be increased in 2021

According to another source, a limited dose of Covid-19 will be available in early November and the supply will be increased in 2021. The U.S. Food and Drug Administration said in a statement that the vaccine was approved "quickly" before the third round of trials.

Other vaccines

However, some of the world's leading pharmaceutical companies and vaccine manufacturers have said that the results of effective vaccines will be available by mid-September. The results of the final round of trials will come in mid-September, according to AstraZeneca, the maker of the world's best-promised covid vaccine, Covishield, also known as the Oxford Vaccines. it was initially reported that the results of the effectiveness of the modern vaccine made in the United States and the results of the German Pfizer Inc. and Biotech SE vaccine will come in mid-October. Chinese vaccine rival Sinovac has already been approved by Beijing, which could come at the same time.

America pays NovaVax

researchers said in New England Journal of Medicine on Wednesday,the vaccine Previous results from the coronavirus vaccine in the United States have shown that it has no serious safety issues and encourage it to boost immunity.

The U.S. government has already paid 1.6 billion to Maryland's NovaVax to develop the vaccine. Two doses of this vaccine will be given every three weeks. The protein in it will build up immunity to coronavirus.